Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicityAlessio Nencioni, Julia Beck, Daniela Werth, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 9, 2019
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradationBianca Sparatore, Marco Pedrazzi, Anna Garuti, et al.
Cancer Letters|March 30, 2018
Squalene epoxidase as a promising metabolic target in cancer treatmentGabriella Cirmena, Paola Franceschelli, Edoardo Isnaldi, et al.
Blood|March 16, 2006
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activationAlessio Nencioni, Karin Schwarzenberg, Katharina M Brauer, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 12, 2009
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samplesPaola Ciotti, Anna Garuti, Alberto Ballestrero, et al.
Current Pharmaceutical Design|September 29, 2012
Rejuvenating sirtuins: the rise of a new family of cancer drug targetsSantina Bruzzone, Marco Daniele Parenti, Alessia Grozio, et al.
Critical Reviews in Oncology/Hematology|December 7, 2007
The use of dendritic cells in cancer immunotherapyAlessio Nencioni, Frank Grünebach, Susanne M Schmidt, et al.
Breast Cancer Research and Treatment|July 14, 2019
Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancerEdoardo Isnaldi, Domenico Ferraioli, Lorenzo Ferrando, et al.
Pageof 13